ArticleNature immunology2020
BATF3 programs CD8
Abstract read
In one paragraph
Article in Nature immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 80 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
80citing papers in PubMed, 1 pooled it
7.9field-weighted citation impact, top 2% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
80 citing papers in PubMed, 1 synthesis or guideline pooled it, 151 citations in OpenAlex.
- Strategies and mechanisms for the enhancement of chimeric antigen receptor T-cell functions.Science China. Life sciences · 2026Pooled it
- TLR9 Agonists Potentiate Adoptive T-cell Therapy in Cancer through a B-cell-CD2 Costimulatory Axis.Cancer research · 2026Article
- Linperlisib enhances MUC1-Tn CAR T cell efficacy by inhibiting EGR1/DUSP2 axis to prevent CAR T cell exhaustion.Leukemia · 2026Article
- BATF3 regulates differentiation of CD8Life science alliance · 2026Article
- Single-cell gain-of-function mapping reveals latent regulatory programs governing CD8Research square · 2026Article
- c-MYC enhances transcription of the type 1 diabetes mellitus associated gene BATF3 via promoter binding.Scientific reports · 2026Article
- Neutrophil Antigen Presentation Reprograms the Tumor Microenvironment and Elicits Durable and Broad Antitumor Immunity.Cancer research communications · 2026Article
- Stepwise epigenetic signal integration drives adaptive programming of cytotoxic lymphocytes.Immunity · 2026Article
- Latent Regulatory Programs Generate Synthetic T Cell States with Enhanced Therapeutic Potential.bioRxiv : the preprint server for biology · 2026Article
- Identification and Validation of BATF3 as a Promising Biomarker Gene for Peripheral T-cell Lymphoma.Current medicinal chemistry · 2026Article
- Gene transfer and genome editing of T cells for cancer immunotherapy: from allogeneic HSCT to TCR gene editing.Hematology. American Society of Hematology. Education Program · 2025Review
- Targeted protein degradation of Wnt/β-catenin signaling pathway: an effective strategy for cancer therapy.Journal of translational medicine · 2025Review
- Functional Specialization and Collaboration of cDC2 Subsets in CD4+ T Cell Priming and Differentiation.Immunological reviews · 2025Review
- Discovery of intrahepatic CD103Experimental & molecular medicine · 2025Article
- Quantifying the impact of genetic mutations on enhancer dynamics.bioRxiv : the preprint server for biology · 2025Article
- Uncovering the individual immunotherapeutic roles of PTPN1 and PTPN2 in T cells during dual inhibition.iScience · 2025Article
- Chromatin landscape alteration uncovers multiple transcriptional circuits during memory CD8+ T-cell differentiation.Protein & cell · 2025Article
- cDC1s Promote Atherosclerosis via Local Immunity and Are Targetable for Therapy.Circulation research · 2025Article
- The immunological interface: dendritic cells as key regulators in metabolic dysfunction-associated steatotic liver disease.FEBS letters · 2025Review
- Single cell transcriptomics in a treatment-segregated cohort exposes a STAT3-regulated therapeutic gap in idiopathic pulmonary fibrosis.bioRxiv : the preprint server for biology · 2025Article
20 more citing papers are in PubMed but not listed here.
Corrections and comments
- Commented on by
Authors and funding
17 authors at 4 institutions in 2 countries.
Marco A Ataide *Würzburg Institute of Systems Immunology, Max-Planck Research Group, University of Würzburg, Würzburg, Germany. marco.ataide@uni-wuerzburg.de.ORCID http://orcid.org/0000-0003-4014-0326
Karl Komander *Würzburg Institute of Systems Immunology, Max-Planck Research Group, University of Würzburg, Würzburg, Germany.
Konrad KnöpperWürzburg Institute of Systems Immunology, Max-Planck Research Group, University of Würzburg, Würzburg, Germany.ORCID http://orcid.org/0000-0003-2076-2160
Annika E PetersWürzburg Institute of Systems Immunology, Max-Planck Research Group, University of Würzburg, Würzburg, Germany.
Hao WuWürzburg Institute of Systems Immunology, Max-Planck Research Group, University of Würzburg, Würzburg, Germany.
Sarah EickhoffWürzburg Institute of Systems Immunology, Max-Planck Research Group, University of Würzburg, Würzburg, Germany.
Tea GogishviliWürzburg Institute of Systems Immunology, Max-Planck Research Group, University of Würzburg, Würzburg, Germany.
Justus WeberMedizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany.ORCID http://orcid.org/0000-0002-4919-952X
Anika GrafenWürzburg Institute of Systems Immunology, Max-Planck Research Group, University of Würzburg, Würzburg, Germany.
Axel KalliesDepartment of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, Australia.ORCID http://orcid.org/0000-0002-6312-6968
Natalio GarbiInstitute of Experimental Immunology, Medical Faculty, University of Bonn, Bonn, Germany.
Hermann EinseleMedizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany.ORCID http://orcid.org/0000-0002-7680-0819
Michael HudecekMedizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany.ORCID http://orcid.org/0000-0003-4048-8824
Georg GasteigerWürzburg Institute of Systems Immunology, Max-Planck Research Group, University of Würzburg, Würzburg, Germany.
Michael HölzelInstitute of Experimental Oncology, Medical Faculty, University of Bonn, Bonn, Germany.
Martin VaethWürzburg Institute of Systems Immunology, Max-Planck Research Group, University of Würzburg, Würzburg, Germany.
Wolfgang KastenmüllerWürzburg Institute of Systems Immunology, Max-Planck Research Group, University of Würzburg, Würzburg, Germany. wolfgang.kastenmueller@uni-wuerzburg.de.ORCID http://orcid.org/0000-0002-3835-1485
University of Würzburg · DEUniversitätsklinikum Würzburg · DEUniversity of Bonn · DEThe University of Melbourne · AU
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antiviral CD8
Indexed as
AnimalsBasic-Leucine Zipper Transcription FactorsCD8-Positive T-LymphocytesCell DifferentiationCell SurvivalCellular ReprogrammingGene ExpressionHumansImmunologic MemoryImmunophenotypingMiceMice, KnockoutMice, TransgenicRepressor ProteinsTranscription FactorsBasic-Leucine Zipper Transcription FactorsBATF3 protein, humanRepressor ProteinsTranscription Factors
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.